首页> Annals of oncology : official journal of the European Society for Medical Oncology> Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.

导出 OA

翻译打印收藏纠错

第一作者： O,Sartor

第一单位： Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, USA;. Electronic address: osartor@tulane.edu.

作者： O,Sartor ^[1] ; D,Heinrich ^[2] ; N,Mariados ^[3] ; M J,Méndez Vidal ^[4] ; D,Keizman ^[5] ; C,Thellenberg Karlsson ^[6] ; A,Peer ^[7] ; G,Procopio ^[8] ; S J,Frank ^[9] ; K,Pulkkanen ^[10] ; E,Rosenbaum ^[11] ; S,Severi ^[12] ; J M,Trigo Perez ^[13] ; V,Wagner ^[14] ; R,Li ^[15] ; L T,Nordquist ^[16]

作者单位： Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, USA;. Electronic address: osartor@tulane.edu. ^[1] Department of Oncology, Akershus University Hospital, Lørenskog, Norway. ^[2] Department of Radiation Oncology, Associated Medical Professionals of New York, PLLC, Syracuse, USA. ^[3] Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofia Hospital, University of Cordoba, Cordoba, Spain. ^[4] Genitourinary Oncology Service, Meir Medical Center, Kfar Saba, Israel. ^[5] Department of Radiation Sciences, Cancer Center Norrlands University, Umeå, Sweden. ^[6] Division of Oncology, Rambam Health Care Campus, Haifa, Israel. ^[7] Fondazione Istituto Nazionale Tumori Oncologia Medica Genitourinaria, Milan, Italy. ^[8] Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. ^[9] Department of Oncology, Kuopio University Hospital, Kuopio, Finland. ^[10] Uro-Oncology Unit, Rabin Medical Center-Davidoff Center, Petah Tikva, Israel. ^[11] Romagnolo Scientific Institute for the Study and Care of Cancer-IRST IRCCS, Nuclear Medicine Therapeutic Unit, Meldola, Italy. ^[12] Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. ^[13] Global Clinical Development, Bayer Pharma AG, Basel, Switzerland. ^[14] Global Research and Development Statistics, Bayer HealthCare Pharmaceuticals, Whippany. ^[15] Department of Medical Oncology, GU Research Network, LLC, Omaha, USA. ^[16]

关键词 bone metastases injections prostate radium-223 re-treatment safety